Annex II
United Kingdom
| Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Specific Conc. Limits,M — Factors | Notes | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) | ||||||
| 015-004-00-8 | aluminium phosphide | 244-088-0 | 20859-73-8 | Water-react. 1 | H260 | GHS02 | H260 | EUH029 | M = 100 | |
| Acute Tox. 2 | H300 | GHS06 | H300 | EUH032 | ||||||
| Acute Tox. 3 | H311 | GHS09 | H311 | |||||||
| Acute Tox. 1 | H330 | Dgr | H330 | |||||||
| Aquatic Acute 1 | H400 | H400 | ||||||||
| 015-005-00-3 | magnesium phosphide; trimagnesium diphosphide | 235-023-7 | 12057-74-8 | Water-react. 1 | H260 | GHS02 | H260 | EUH029 | M = 100 | |
| Acute Tox. 2 | H300 | GHS06 | H300 | EUH032 | ||||||
| Acute Tox. 3 | H311 | GHS09 | H311 | |||||||
| Acute Tox. 1 | H330 | Dgr | H330 | |||||||
| Aquatic Acute 1 | H400 | H400 | ||||||||
| 015-123-00-5 | fenamiphos (ISO); ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate | 244-848-1 | 22224-92-6 | Acute Tox. 2 | H300 | GHS06 | H300 | M = 100 M = 100 | ||
| Acute Tox. 2 | H310 | GHS09 | H310 | |||||||
| Acute Tox. 2 | H330 | Dgr | H330 | |||||||
| Eye Irrit. 2 | H319 | H319 | ||||||||
| Aquatic Acute 1 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| 030-012-00-1 | aluminium-magnesium-zinc-carbonate-hydroxide | 423-570-6 | 169314-88-9 | Aquatic Chronic 4 | H413 | H413 | ||||
| 602-006-00-4 | chloroform; trichloromethane | 200-663-8 | 67-66-3 | Carc. 2 | H351 | GHS06 | H351 | |||
| Repr. 2 | H361d | GHS08 | H361d | |||||||
| Acute Tox. 3 | H331 | Dgr | H331 | |||||||
| Acute Tox. 4 | H302 | H302 | ||||||||
| STOT RE 1 | H372 | H372 | ||||||||
| Eye Irrit. 2 | H319 | H319 | ||||||||
| Skin Irrit. 2 | H315 | H315 | ||||||||
| 603-097-00-3 | 1,1’,1’-nitrilotripropan-2-ol; triisopropanolamine | 204-528-4 | 122-20-3 | Eye Irrit. 2 | H319 | GHS07 Wng | H319 | |||
| 605-008-00-3 | acrolein; prop-2-enal; acrylaldehyde | 203-453-4 | 107-02-8 | Flam. Liq. 2 | H225 | GHS02 | H225 | EUH071 | Skin Corr. 1; H314: C ≥ 0,1 % | D |
| Acute Tox. 1 | H330 | GHS06 | H330 | |||||||
| Acute Tox. 2 | H300 | GHS05 | H300 | |||||||
| Acute Tox. 3 | H311 | GHS09 | H311 | |||||||
| Skin Corr. 1 | H314 | Dgr | H314 | |||||||
| Aquatic Acute 1 | H400 | M = 100 | ||||||||
| Aquatic Chronic 1 | H410 | H410 | M = 1 | |||||||
| 607-023-00-0 | vinyl acetate | 203-545-4 | 108-05-4 | Flam. Liq. 2 | H225 | GHS02 | H225 | D | ||
| Carc. 2 | H351 | GHS08 | H351 | |||||||
| Acute Tox. 4 | H332 | GHS07 | H332 | |||||||
| STOT SE 3 | H335 | Dgr | H335 | |||||||
| 607-613-00-8 | reaction mass of:
| 432-790-1 | Acute Tox. 4* | H332 | GHS07 | H332 | ||||
| Acute Tox. 4* | H312 | GHS05 | H312 | |||||||
| Acute Tox. 4* | H302 | GHS08 | H302 | |||||||
| Skin Corr. 1B | H314 | Dgr | H314 | |||||||
| STOT SE 2 | H371 (eyes) | H371 (eyes) | ||||||||
| 609-003-00-7 | nitrobenzene | 202-716-0 | 98-95-3 | Carc. 2. | H351 | GHS06 | H351 | |||
| Repr. 1B | H360F | GHS08 | H360F | |||||||
| Acute Tox. 3 | H301 | Dgr | H301 | |||||||
| Acute Tox. 3 | H331 | H331 | ||||||||
| Acute Tox. 3 | H311 | H311 | ||||||||
| STOT RE 1 | H372 (blood) | H372 (blood) | ||||||||
| Aquatic Chronic 3 | H412 | H412 | ||||||||
| 612-120-00-6 | aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline | 277-704-1 | 74070-46-5 | Carc. 2 | H351 | GHS08 | H351 | M = 100 M = 10 | ||
| Skin Sens. 1A | H317 | GHS07 | H317 | |||||||
| Aquatic Acute 1 | H400 | GHS09 | ||||||||
| Aquatic Chronic 1 | H410 | Wng | H410 | |||||||
| 613-175-00-9 | epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[( 1H-1,2,4-triazol-1-yl)methyl]oxirane | 406-850-2 | 133855-98-8 | Carc. 2 | H351 | GHS08 | H351 | |||
| Repr. 1B | H360Df | GHS09 | H360Df | |||||||
| Aquatic Chronic 2 | H411 | Dgr | H411 | |||||||
| 616-200-00-1 | reaction mass of N,N’-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide) | 432-430-3 | Aquatic Chronic 4 | H413 | H413 | |||||
| 648-055-00-5 | pitch, coal tar, high-temp.; [The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] | 266-028-2 | 65996-93-2 | Carc. 1A | H350 | GHS08 | H350 | M = 1000 M = 1000 | ||
| Muta. 1B | H340 | GHS09 | H340 | |||||||
| Repr. 1B | H360FD | Dgr | H360FD | |||||||
| Aquatic Acute 1 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| 649-330-00-2 | naphtha (petroleum), hydrodesulphurized heavy; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).] | 265-185-4 | 64742-82-1 | Carc. 1B | H350 | GHS08 | H350 | P | ||
| Muta. 1B | H340 | Dgr | H340 | |||||||
| STOT RE 1 | H372 (central nervous system) | H372 (central nervous system) | ||||||||
| Asp. Tox. 1 | H304 | H304 | ||||||||
| 649-345-00-4 | stoddard solvent; Low boiling point naphtha — unspecified; [A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).] | 232-489-3 | 8052-41-3 | Carc. 1B | H350 | GHS08 | H350 | P | ||
| Muta. 1B | H340 | Dgr | H340 | |||||||
| STOT RE 1 | H372 (central nervous system) | H372 (central nervous system) | ||||||||
| Asp. Tox. 1 | H304 | H304 | ||||||||
| 649-405-00-X | solvent naphtha (petroleum), medium aliph.; Straight run kerosine; [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).] | 265-191-7 | 64742-88-7 | STOT RE 1 | H372 (central nervous system) | GHS08 | H372 (central nervous system) | |||
| Asp. Tox. 1 | H304 | Dgr | H304 | |||||||